Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.55 |
| ▸ | CTSL | P07711 | 2/20 | 0.53 |
| ▸ | CTSS | P25774 | 2/20 | 0.53 |
| ▸ | CTSK | P43235 | 2/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | NPY4R | P50391 | 11/20 | 0.48 |
| ▸ | NPY1R | P25929 | 7/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.46 |
| ▸ | NPY2R | P49146 | 3/20 | 0.46 |
| ▸ | REN | P00797 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29492566 | 1.00 | CAPN1 (0.55) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL29734569 | 0.92 | CTSK (0.50) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL23728734 | 0.92 | CTSK (0.50) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL23728735 | 0.92 | CTSK (0.50) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL25696029 | 0.92 | CTSK (0.50) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL21323138 | 0.91 | CAPN1 (0.57) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL7106632 | 0.91 | CAPN1 (0.56) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL30141950 | 0.90 | CAPN1 (0.46) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL1486276 | 0.90 | MEN1 (0.55) | CAPN1CTSLCTSSCTSKCTSB | |
| SCHEMBL2367531 | 0.90 | MEN1 (0.55) | CAPN1CTSLCTSSCTSKCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110105428-B | Leu-Arg-Ala-Pro-Leu-Tyr-Val heptapeptide, synthesis, activity and application thereof | 首都医科大学 | 2022-08-05 | — | — | CN | disclosed |
| CN-109438363-B | Liquid-phase high-purity large-scale synthesis method of cyclic (leucyl-arginyl) dipeptide salt | 陕西慧康生物科技有限责任公司 | 2022-04-29 | — | — | CN | disclosed |